Average Co-Inventor Count = 7.19
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nurix Therapeutics, Inc. (7 from 14 patents)
2. Chemocentryx, Inc. (4 from 215 patents)
11 patents:
1. 12234230 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
2. 12121540 - CBL inhibitors and compositions for use in adoptive cell therapy
3. 12049471 - Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
4. 11951133 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
5. 11530229 - Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
6. 11464802 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
7. 11401267 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
8. RE39849 - Methods for identifying modulators of CCX CKR activity
9. 7108990 - Chemokine receptor
10. 6998239 - Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
11. 6835547 - Methods for identifying modulators of CCX CKR activity